Flunisolide Solution
Product Images NDC 50742-317
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Flunisolide (NDC 50742-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Figure0008)
Figure (Figure001)
Figure (Figure02)
Figure (Figure03)
Figure (Figure04)
Figure (Figure05)
Figure (Figure07)
Figure (Figure09)
Label (Image0002)
Flunisolide Nasal Solution is a prescription medication intended for intranasal use only. Each spray delivers 25mcg flunisolide. The solution contains active ingredients such as Flunisolide 0.25mg (0.025%) and other inactive ingredients such as Propylene Glycol, Polyethylene Glycol 3350, Butylated Hydroxyanisole, Edetate Disodium, Sodium Citrate, Citric Acid, and Purified Water. Sodium Hydroxide and/or Hydrochloric Acid may be added to adjust pH (5.1 - 5.4). The medicine is available in 25mL with 200 metered sprays. Refer to the package insert for complete prescribing information and instructions for using the nasal pump. The solution should be stored at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). Keep it out of reach of children.*
Carton (Image001)
Flunisolide (structural Formula) (Structure0001)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.